58468-0357Level 3
Campath (ALEMTUZUMAB)
**Product type:** Human Prescription Drug
**Active ingredient:** ALEMTUZUMAB
**Strength:** 30 mg/mL
**Dosage form:** Injection
**Route:** Intravenous
**Labeler:** Genzyme Corporation
**Marketing category:** BLA (BLA103948)
**Pharmacologic class:** CD52-directed Antibody Interactions [MoA], CD52-directed Cytolytic Antibody [EPC]
GET
/api/v1/systems/ndc_fda/nodes/58468-0357Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.